Feed/Companies/Bionyra Pharma

Bionyra Pharma

As of 14 Oct 2026, Bionyra Pharma has raised $165M across 1 verified round on record; latest: $165 million Series A led by Jeito Capital and Sofinnova Partners, announced 22 Jun 2026.

BUILT ON

Visit site

Bionyra Pharma is a clinical-stage biopharmaceutical company developing next-generation biologics for severe immune-mediated inflammatory diseases.

bionyra.comLinkedInParis & BostonBiotech

LATEST ROUND

Series A

$165M · 2026-06-22

RAISED ON RECORD · USD

$165M

across 1 verified round

INVESTORS

2 leads

SOURCES

from 1 publisher

Feed/Companies

Company

Every round on record, with the sources behind each and the investors on them.

BUILT ON

Series A

$165M · 2026-06-22

[ HISTORY ]

led by Jeito Capital, Sofinnova Partners

Round	Amount	Announced	Lead	Buzz
Series A [ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it.	$165M	2026-06-22	Jeito Capital, Sofinnova Partners	No recent discussion
1 source [ VERIFIED ] read against 1 source The release gives a Paris & Boston dateline, not the company's headquarters.

Bionyra Pharma

Company

Rounds

Sources

Profile

Investors

Bionyra Pharma

Rounds

Profile

Sources

Series A$165M2026-06-221 source

Investors

Series A$165M2026-06-227 investors